PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Brian Brown, Ph.D., inducted into AIMBE College of Fellows for pioneering contributions in gene therapy and functional genomics

Brian Brown, Ph.D., inducted into AIMBE College of Fellows for pioneering contributions in gene therapy and functional genomics
2025-03-31
(Press-News.org) New York, NY [March 31, 2025] — Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). He was honored for his seminal work in gene therapy and functional genomics, which has helped transform the fields and contributed to key advancements in medicine and biotechnology.

Election to the AIMBE College of Fellows is one of the highest professional distinctions in the field. It recognizes the top two percent of experts in medical and biological engineering, and its members are celebrated for their exceptional work in the field.

Members are honored for their outstanding contributions to "engineering and medicine research, practice, or education” and to "the pioneering of new and developing fields of technology." Dr. Brown’s election recognizes his groundbreaking work developing innovative technologies that have been broadly used across biomedical fields, including in cancer, immunology, and genetic disease research and therapeutic development.

He joins an esteemed group of Fellows, including Nobel laureates and recipients of the Presidential Medal of Science and the National Medal of Technology and Innovation. This recognition further underscores Mount Sinai's leadership in advancing cutting-edge biomedical research.

“We are enormously proud of Brian for this well-deserved recognition from the AIMBE College of Fellows. His pioneering contributions to gene therapy and functional genomics are propelling the frontiers of precision medicine and transformative patient care,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “This prestigious honor reflects his exceptional leadership and the innovative work being done at the Icahn Genomics Institute. At Mount Sinai, we remain committed to fostering innovation that translates into meaningful improvements in patient outcomes, and Brian’s accomplishments are a shining example of this mission in action.”

Dr. Brown is also Vice Chair of the Department of Immunology and Immunotherapy and Associate Director of the Marc and Jennifer Lipschultz Precision Immunology Institute
and Mount Sinai Professor of Genetic Engineering at Mount Sinai. A distinguished immunologist and molecular biologist, he has developed several key technologies. This includes synthetic microRNA target sites for cell-specific control of gene, virus, and RNA drugs, macrophage-targeting CAR T cells for cancer therapy, and bispecific antibody-coupled lipid nanoparticles for precision mRNA delivery.

His lab has also invented many novel functional genomics technologies, including genome-wide microRNA sensor libraries, high-scale protein barcode technology (Pro-Code), and the first spatial functional genomics platform (Perturb-map), which is a breakthrough for CRISPR screening by enabling single-cell and spatial analysis. These innovations are helping to shape the future of genomic research and personalized medicine. In addition to his visionary work in gene therapy and functional genomics, Dr. Brown has made significant contributions to our understanding of immune cell biology and tumor immunity.

“I am deeply honored to be inducted into the AIMBE College of Fellows. The major advances we are seeing in medicine and science are thanks to the technological advances made by this incredible group of innovators,” says Dr. Brown. “This recognition is a testament to the hard work and dedication of my exceptional lab and the outstanding researchers at the Icahn Genomics Institute. Together, we are committed to advancing new disease treatments, and I am grateful to be part of a community that is making meaningful contributions to medicine. We will continue pushing the boundaries of science and technology, with the ultimate goal of improving patient outcomes and transforming health care.”

Dr. Brown was inducted into the 2025 Class of Fellows during a formal ceremony today at the AIMBE Annual Event in Arlington, Virginia.

AIMBE Fellows are among the most distinguished medical and biological engineers including four Nobel Prize laureates and 27 Presidential Medal of Science and/or Technology and Innovation awardees. Additionally, 233 Fellows have been inducted into the National Academy of Engineering, 120 into the National Academy of Medicine, and 51 into the National Academy of Sciences.

About AIMBE

AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize excellence, advance public understanding, and accelerate medical and biological innovation. No other organization brings together academic, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on Capitol Hill and beyond.

About the Icahn School of Medicine at Mount Sinai 

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.  

The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 500 postdoctoral research fellows. 

 

Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges.  More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.

------------------------------------------------------- 

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.  

 

 

END


[Attachments] See images for this press release:
Brian Brown, Ph.D., inducted into AIMBE College of Fellows for pioneering contributions in gene therapy and functional genomics

ELSE PRESS RELEASES FROM THIS DATE:

My robot therapist: The ethics of AI mental health chatbots for kids

2025-03-31
Mental health care can be difficult to access in the U.S. Insurance coverage is spotty and there aren’t enough mental health professionals to cover the nation’s need, leading to long waits and costly care. Enter artificial intelligence (AI). AI mental health apps, ranging from mood trackers to chatbots that mimic human therapists, are proliferating on the market. While they may offer a cheap and accessible way to fill the gaps in our system, there are ethical concerns about overreliance on ...

Rice scientists pioneer method to tackle ‘forever chemicals’

2025-03-31
Rice University researchers have developed an innovative solution to a pressing environmental challenge: removing and destroying per- and polyfluoroalkyl substances (PFAS), commonly called “forever chemicals.” A study led byJames Tour, the T.T. and W.F. Chao Professor of Chemistry and professor of materials science and nanoengineering, and graduate student Phelecia Scotland unveils a method that not only eliminates PFAS from water systems but also transforms waste into high-value graphene, offering a cost-effective and sustainable approach to environmental remediation. This research was published March 31 in Nature Water. PFAS ...

Exploring why some athletes perform better than others under stress

2025-03-31
Lack of sleep and stress hinder athletic performance, but some athletes may be better at performing competitively despite sleep issues and stress. In a new JNeurosci paper, researchers led by Yan Sun, from Peking University, looked for predictive behavioral and neural markers in athletes who maintain their performance level following sleep deprivation and under stress.  The researchers assessed college and professional athletes’ stress levels and cognitive changes after 24 h of sleep deprivation, then followed their ...

Exploring binge eating and binge drinking alcohol comorbidity

2025-03-31
The comorbidity of binge eating and alcohol binge drinking is prevalent and increases the risk of other neuropsychiatric and bodily conditions. However, the mechanisms linking these forms of binge consumption are unclear. To explore the link between binge eating and binge drinking alcohol, Karen Szumlinski, from the University of California, Santa Barbara, and colleagues developed a way to model the disease comorbidity in mice. As reported in their JNeurosci paper, this mouse model led to the discovery that females with a history of binge eating start binge drinking ...

The proportion of harmful substances in particulate matter is much higher than assumed

2025-03-31
People breathing contaminated air over the course of years are at greater risk of developing numerous diseases. This is thought to be due to highly reactive components in particulate matter, which affect biological processes in the body. However, researchers from the University of Basel, Switzerland, have now shown that precisely these components disappear within hours and that previous measurements therefore completely underestimate the quantities in which they are present. From chronic respiratory problems to cardiovascular diseases, ...

Administration is weakening U.S. research capacity and endangering Americans, nation’s leading scientists warn

2025-03-31
The wellbeing of Americans and the country’s longstanding position as a world leader in science and technology are in jeopardy due to the actions of the Trump administration, approximately 1,900 leading figures in medicine, science, and engineering warn today in an open statement to the American public. The list of signatories includes Nobel Prize winners, deans of medical schools, and national leaders in science and technology. “For over 80 years, wise investments by the US government have built up the nation’s research enterprise, making it the envy of ...

Trade Tariffs on Canadian Pharmaceuticals— Implications for US Drug Supply and Costs

2025-03-31
About The Study: Although Canada is not the largest supplier of medications to the U.S., tariffs could raise costs and strain supply chains. This study estimates that $3 billion in U.S. pharmaceuticals depend on Canadian manufacturing, with 25% tariffs adding $750 million in cost. Although the Inflation Reduction Act provisions limit cost pass-through to some payers (i.e., Medicare), manufacturers may still adjust production or alter distribution, increasing supply chain fragility. Corresponding Author: To contact the corresponding author, Mina Tadrous, PharmD, PhD, email mina.tadrous@utoronto.ca. To access the embargoed study: Visit our For The Media website ...

Cardiovascular Health Among Rural and Urban US Adults— Healthcare, Lifestyle, and Social Factors

2025-03-31
About The Study: This national cross-sectional study found substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases, which were largest among younger adults and almost entirely explained by social risk factors. These findings suggest that efforts to improve socioeconomic conditions in rural communities may be critical to address the rural-urban gap in cardiovascular health. Corresponding Author: To contact the corresponding author, Rishi K. Wadhera, MD, MPP, MPhil, email rwadhera@bidmc.harvard.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamacardio.2025.0538) Editor’s ...

Study finds gap between heart disease outcomes in men and women has narrowed over past 20 years

Study finds gap between heart disease outcomes in men and women has narrowed over past 20 years
2025-03-31
While the typical image of someone suffering a heart attack might be a man clutching his chest, heart disease is a major problem for women, too. In fact, it’s the leading cause of death among women in the United States, with nearly 45% of the nation’s women over age 20 living with some form of cardiovascular disease. A new study from heart researchers at Intermountain Health in Salt Lake City shows that while rates of death and other cardiac-related events – like heart attack ­– are still high for women, the ...

New study links lower proportions of certain sleep stages to brain changes associated with Alzheimer’s disease

2025-03-31
DARIEN, IL — New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer’s disease over time. Results show that individuals with lower proportions of time spent in slow wave sleep and rapid eye movement sleep had smaller volumes in critical brain regions, particularly the inferior parietal region, which is known to undergo early structural changes in Alzheimer’s disease. The results were adjusted for potential confounders including demographic characteristics, smoking history, alcohol use, hypertension, and coronary heart disease. “Our findings provide ...

LAST 30 PRESS RELEASES:

New research boosts future whooping cough vaccines

Mechanistic understanding could enable better fast-charging batteries

No bones about it: new details about skeletal cell aging revealed

UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue

UMaine research examines best methods for growing Atlantic sea scallops

Medical cannabis could speed recovery, especially at community recovery homes

Study assesses U.S. image amid weakening of democracy

Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health

Researchers improve chemical reaction that underpins products from foods to fuels

Texas Tech to develop semiconductor power devices through $6 million grant

Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells

Hot Schrödinger cat states created

How cells repair their power plants

Oxygen is running low in inland waters—and humans are to blame

ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain

Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity

How a small number of mutations can fuel outbreaks of western equine encephalitis virus

Exposure to wildfire smoke linked with worsening mental health conditions

Research uncovers hidden spread of one of the most common hospital-associated infections

Many older adults send their doctors portal messages, but who pays?

Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits

Gender inequity in institutional leadership roles in US academic medical centers

Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations

Rare combination of ovarian tumors found in one patient

AI-driven clinical recommendations may aid physician decision making to improve quality of care

Artificial intelligence has potential to aid physician decisions during virtual urgent care

ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025

New study reveals polymers with flawed fillers boost heat transfer in plastics

Signs identified that precede sudden arrhythmic death syndrome in young people

Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance

[Press-News.org] Brian Brown, Ph.D., inducted into AIMBE College of Fellows for pioneering contributions in gene therapy and functional genomics